AHIP

Experts on AI spoke about strategies and tactics for implementing artificial intelligence that would assuage worries and build trust during a keynote session at AHIP annual meeting.

Even though value-based care has been talked about for a long time, it may not be the end.

In 2024, there have been two common health plan issues brought up by employers.

Harvard researcher Zirui Song says research findings show that nospitals higher prices and lower quality.

CNN political commentators Scott Jennings and Van Jones briefly touched on the upcoming election’s impact on healthcare at the annual AHIP meeting in Las Vegas.

Hackers are learning health plans’ infrastructure and are attacking the places with the highest value information. Transferring data is the weakest point in the healthcare ecosystem, panelists said at the AHIP meeting in Las Vegas.

Karen Schulte, president of SCAN Health Plan, spoke with Managed Healthcare Executive in this part two conversation held prior to Schulte’s presentation on June 12 at AHIP 2024 in Las Vegas.

Increased health demand, decreased physician workforce, technology advancements and more government involvement in healthcare present challenges — and opportunities — for health plans, said session panelists at the annual AHIP meeting in Las Vegas.

In a conversation prior to the AHIP 2024 Meeting in Las Vegas, Managed Healthcare Executive chatted with Karen Schulte, president of SCAN Health Plan, about her presentation on segmentation and customized analysis on June 12.

Three speakers, three different takes on the state of U.S. healthcare and what ails it.

Working with providers to align goals and objectives will lead to better and more successful programs to help manage complex and costly medical conditions, said panelists at the annual AHIP meeting in Las Vegas.

In an interview prior to the AHIP 2024 conference in Las Vegas, MHE spoke with Sachin H. Jain, M.D.,MBA, CEO, SCAN Group and SCAN Health Plan, who acknowledged that while SCAN isn't perfect, they are ahead in simplifying healthcare by recognizing their role in the problem.

In an interview prior to the AHIP 2024 conference in Las Vegas, MHE spoke with Sachin H. Jain, M.D.,MBA, CEO, SCAN Group and SCAN Health Plan, about the need to reimagine U.S. healthcare, emphasizing a leadership crisis.

CDC Director Mandy K. Cohen spabout the agency modernizing data and working with payers and other parts of the healthcare system at the AHIP meeting in Las Vegas.

In an interview, Timothy Law, DO, MBA, chief medical officer of Highmark, talks about how GLP-1 agonist drugs like Wegovy and Zepbound are changing the paradigm for weight loss.

In an interview, Timothy Law, DO, MBA, chief medical officer of Highmark, talks about the issues insurers consider when providing coverage for GLP-1 drugs like Wegovy and Zepbound that can help patients lose weight.

Geeta Nayyar, M.D., a rheumatologist and author, discusses how misinformation and disinformation is eroding the trust between doctors and patients, and how healthcare organizations can be part of the solution.

Merith Basey, executive director of Patients for Affordable Drug, talks about strategies for lowering the cost of new drugs, especially cell and gene therapy, in a second part of a video interview conducted prior to the June 11-13 AHIP 2024 meeting in Las Vegas.

Merith Basey, M.Sc., executive director of Patients for Affordable Drugs, discusses her group's focus on the monopoly pricing of pharmaceutical companies and bills in Congress addressing patent reform and "pay for delay" strategies, in an interview with MHE previewing the presentation she's co-presenting on June 11 at the AHIP 2024 meeting in Las Vegas.

Public health, artificial intelligence and GLP-1s are on the agenda of the June 11-13 meeting in Las Vegas.